Tag: Vaginal Problems
2011 FDA Safety Message Tied to Drop in Transvaginal Mesh Use
Proportion of apical procedures using transvaginal mesh decreased in year after safety communication
FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women
Remaining manufacturers have failed to prove the long-term safety or benefit of their devices
Doctors Question State Lawsuits Over Pelvic Mesh Products
Lawsuits claim Johnson & Johnson did not fully disclose safety risks of transvaginal mesh products
Gabapentin Improves Sexual Function in Provoked Vulvodynia
Sexual function improved for gabapentin vs. placebo, but still lower than among matched pain-free controls
Postmenopausal Vaginal Estrogen Not Tied to Negative Health Outcomes
No difference in cardiovascular disease, cancer, hip fracture for users or nonusers of vaginal estrogen
Delivery Mode Tied to Pelvic Floor Disorder Risk Post-Childbirth
Larger genital hiatus tied to higher pelvic organ prolapse risk, regardless of delivery mode
Age-Related Vaginal Symptoms Tied to Worse Quality of Life
Burden of severe symptoms is high among postmenopausal women
FDA Warns of the Dangers of ‘Vaginal Rejuvenation’
Numerous cases of vaginal burns or scarring have been linked to the procedures
Low-Dose Vaginal Estradiol Improves Menopause-Linked QOL
Significant improvement in total MENQOL scores, MENQOL sexual function domain for vaginal estradiol
Energy-Based Devices Work Well for Feminine Rejuvenation
Nonsurgical treatments for feminine genital rejuvenation found to be effective, well tolerated
